These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26930566)

  • 1. In vitro skin permeation of artemisone and its nano-vesicular formulations.
    Dwivedi A; Mazumder A; Fox LT; Brümmer A; Gerber M; du Preez JL; Haynes RK; du Plessis J
    Int J Pharm; 2016 Apr; 503(1-2):1-7. PubMed ID: 26930566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells.
    Dwivedi A; Mazumder A; du Plessis L; du Preez JL; Haynes RK; du Plessis J
    Nanomedicine; 2015 Nov; 11(8):2041-50. PubMed ID: 26282380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical Delivery of
    Chinembiri TN; Gerber M; du Plessis LH; du Preez JL; Hamman JH; du Plessis J
    Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S663-S671. PubMed ID: 29142430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical Delivery of Artemisone, Clofazimine and Decoquinate Encapsulated in Vesicles and Their In vitro Efficacy Against Mycobacterium tuberculosis.
    van Zyl L; Viljoen JM; Haynes RK; Aucamp M; Ngwane AH; du Plessis J
    AAPS PharmSciTech; 2019 Jan; 20(1):33. PubMed ID: 30604176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of Natural Oil Nano-Emulsions for the Topical Delivery of Clofazimine, Artemisone and Decoquinate.
    Burger C; Aucamp M; du Preez J; Haynes RK; Ngwane A; du Plessis J; Gerber M
    Pharm Res; 2018 Aug; 35(10):186. PubMed ID: 30088097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-formulation for topical treatment of precancerous lesions: skin penetration, in vitro, and in vivo toxicological evaluation.
    Calienni MN; Temprana CF; Prieto MJ; Paolino D; Fresta M; Tekinay AB; Alonso SDV; Montanari J
    Drug Deliv Transl Res; 2018 Jun; 8(3):496-514. PubMed ID: 29288359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin Transport of Hydrophilic Compound-Loaded PEGylated Lipid Nanocarriers: Comparative Study of Liposomes, Niosomes, and Solid Lipid Nanoparticles.
    Rangsimawong W; Opanasopit P; Rojanarata T; Duangjit S; Ngawhirunpat T
    Biol Pharm Bull; 2016; 39(8):1254-62. PubMed ID: 27476936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical Delivery of 5-Fluorouracil from Pheroid™ Formulations and the In Vitro Efficacy Against Human Melanoma.
    Chinembiri TN; Gerber M; du Plessis L; du Preez J; du Plessis J
    AAPS PharmSciTech; 2015 Dec; 16(6):1390-9. PubMed ID: 25956486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin Localization of Lipid Nanoparticles (SLN/NLC): Focusing the Influence of Formulation Parameters.
    Amasya G; Sandri G; Onay-Besikci A; Badilli U; Caramella C; Bonferoni MC; Tarimci N
    Curr Drug Deliv; 2016; 13(7):1100-1110. PubMed ID: 26725723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the skin barrier and its modulation by vesicular formulations.
    Bouwstra JA; Honeywell-Nguyen PL; Gooris GS; Ponec M
    Prog Lipid Res; 2003 Jan; 42(1):1-36. PubMed ID: 12467638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of the Penetration and Permeation of Caffeine into and through Human Epidermis after Application in Various Vesicle Formulations.
    Abd E; Roberts MS; Grice JE
    Skin Pharmacol Physiol; 2016; 29(1):24-30. PubMed ID: 26540487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of liposomes and niosomes on skin permeation of enoxacin.
    Fang JY; Hong CT; Chiu WT; Wang YY
    Int J Pharm; 2001 May; 219(1-2):61-72. PubMed ID: 11337166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy.
    Dorrani M; Garbuzenko OB; Minko T; Michniak-Kohn B
    J Control Release; 2016 Apr; 228():150-158. PubMed ID: 26965957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-based nanoformulation optimization for achieving cutaneous targeting: Niosomes as the potential candidates to fulfill this aim.
    Lin YK; Hsiao CY; Alshetaili A; Aljuffali IA; Chen EL; Fang JY
    Eur J Pharm Sci; 2023 Jul; 186():106458. PubMed ID: 37137418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved photostability, reduced skin permeation and irritation of isotretinoin by solid lipid nanoparticles.
    Shiva G; Somaye M; Reza JM
    Acta Pharm; 2012 Dec; 62(4):547-62. PubMed ID: 23333889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes and niosomes as topical drug delivery systems.
    Choi MJ; Maibach HI
    Skin Pharmacol Physiol; 2005; 18(5):209-19. PubMed ID: 16015019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin cancer: symptoms, mechanistic pathways and treatment rationale for therapeutic delivery.
    Goyal N; Thatai P; Sapra B
    Ther Deliv; 2017 Mar; 8(5):265-287. PubMed ID: 28361609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
    Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
    Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation.
    Clares B; Calpena AC; Parra A; Abrego G; Alvarado H; Fangueiro JF; Souto EB
    Int J Pharm; 2014 Oct; 473(1-2):591-8. PubMed ID: 25102113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of solid lipid nanoparticles for caffeine topical administration.
    Puglia C; Offerta A; Tirendi GG; Tarico MS; Curreri S; Bonina F; Perrotta RE
    Drug Deliv; 2016; 23(1):36-40. PubMed ID: 24735249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.